Skip to Main Content
Contribute Try STAT+ Today

When consumer genetics firm 23andMe announced Thursday that it will go public through a deal with the special purpose acquisition corporation VG Acquisition Corp, STAT hopped onto a Zoom call with two of the most prominent and colorful people in the business world: 23andMe co-founder Anne Wojcicki, who has run the company from its start, and Richard Branson, the billionaire idea-man behind everything emblazoned with the word Virgin.

The conversation offered a window into why the pair thinks 23andMe is worth an eye-popping $3.5 billion. Zoom cameras stayed off, as all participants said they were not quite camera-ready, and, in fact, at least two were in pajamas.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.